nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.326	1	CrCtD
Fludrocortisone—NR3C2—dilated cardiomyopathy	0.224	1	CbGaD
Fludrocortisone—NR3C2—Spironolactone—dilated cardiomyopathy	0.115	0.541	CbGbCtD
Fludrocortisone—AR—Spironolactone—dilated cardiomyopathy	0.0597	0.28	CbGbCtD
Fludrocortisone—NR3C1—Spironolactone—dilated cardiomyopathy	0.038	0.178	CbGbCtD
Fludrocortisone—Eplerenone—Spironolactone—dilated cardiomyopathy	0.0275	0.131	CrCrCtD
Fludrocortisone—Dydrogesterone—Spironolactone—dilated cardiomyopathy	0.0218	0.104	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Spironolactone—dilated cardiomyopathy	0.0208	0.0994	CrCrCtD
Fludrocortisone—Megestrol acetate—Spironolactone—dilated cardiomyopathy	0.019	0.0909	CrCrCtD
Fludrocortisone—Medroxyprogesterone Acetate—Spironolactone—dilated cardiomyopathy	0.0169	0.0809	CrCrCtD
Fludrocortisone—Hydrocortamate—Spironolactone—dilated cardiomyopathy	0.0153	0.073	CrCrCtD
Fludrocortisone—Cortisone acetate—Spironolactone—dilated cardiomyopathy	0.0148	0.0707	CrCrCtD
Fludrocortisone—Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.0132	0.0631	CrCrCtD
Fludrocortisone—Progesterone—Spironolactone—dilated cardiomyopathy	0.0129	0.0615	CrCrCtD
Fludrocortisone—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.0129	0.0615	CrCrCtD
Fludrocortisone—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.0125	0.0599	CrCrCtD
Fludrocortisone—Testosterone—Spironolactone—dilated cardiomyopathy	0.0112	0.0533	CrCrCtD
Fludrocortisone—Hydrocortisone—Spironolactone—dilated cardiomyopathy	0.0105	0.0501	CrCrCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00216	0.251	CbGpPWpGaD
Fludrocortisone—Angiitis necrotising—Furosemide—dilated cardiomyopathy	0.00181	0.119	CcSEcCtD
Fludrocortisone—Glucose tolerance decreased—Furosemide—dilated cardiomyopathy	0.00165	0.108	CcSEcCtD
Fludrocortisone—Vasculitis necrotising—Furosemide—dilated cardiomyopathy	0.00158	0.104	CcSEcCtD
Fludrocortisone—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.00123	0.0808	CcSEcCtD
Fludrocortisone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0011	0.0722	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.000907	0.106	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.000774	0.0901	CbGpPWpGaD
Fludrocortisone—Diabetic—Lisinopril—dilated cardiomyopathy	0.000745	0.0489	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.000698	0.0811	CbGpPWpGaD
Fludrocortisone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.000693	0.0455	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000491	0.0571	CbGpPWpGaD
Fludrocortisone—Glycosuria—Furosemide—dilated cardiomyopathy	0.000409	0.0269	CcSEcCtD
Fludrocortisone—Eplerenone—NR3C2—dilated cardiomyopathy	0.000325	0.281	CrCbGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000324	0.0376	CbGpPWpGaD
Fludrocortisone—NR3C2—cardiac ventricle—dilated cardiomyopathy	0.000308	0.139	CbGeAlD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000303	0.0353	CbGpPWpGaD
Fludrocortisone—NR3C2—myocardium—dilated cardiomyopathy	0.00029	0.131	CbGeAlD
Fludrocortisone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000278	0.0182	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000277	0.0182	CcSEcCtD
Fludrocortisone—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000269	0.0177	CcSEcCtD
Fludrocortisone—Purpura—Furosemide—dilated cardiomyopathy	0.00025	0.0164	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000249	0.0163	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000246	0.0286	CbGpPWpGaD
Fludrocortisone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000236	0.0155	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.00023	0.0268	CbGpPWpGaD
Fludrocortisone—AR—cardiac ventricle—dilated cardiomyopathy	0.000228	0.103	CbGeAlD
Fludrocortisone—Spironolactone—NR3C2—dilated cardiomyopathy	0.000222	0.192	CrCbGaD
Fludrocortisone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000217	0.0143	CcSEcCtD
Fludrocortisone—AR—myocardium—dilated cardiomyopathy	0.000214	0.0969	CbGeAlD
Fludrocortisone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000212	0.0139	CcSEcCtD
Fludrocortisone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000209	0.0137	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000208	0.0136	CcSEcCtD
Fludrocortisone—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000204	0.0134	CcSEcCtD
Fludrocortisone—NR3C2—heart—dilated cardiomyopathy	0.000202	0.0913	CbGeAlD
Fludrocortisone—Injury—Lisinopril—dilated cardiomyopathy	0.000196	0.0129	CcSEcCtD
Fludrocortisone—Prednisolone—NR3C2—dilated cardiomyopathy	0.000193	0.166	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000191	0.0222	CbGpPWpGaD
Fludrocortisone—Betamethasone—NR3C2—dilated cardiomyopathy	0.000189	0.163	CrCbGaD
Fludrocortisone—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000188	0.0123	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000187	0.0122	CcSEcCtD
Fludrocortisone—NR3C2—cardiac atrium—dilated cardiomyopathy	0.000173	0.0781	CbGeAlD
Fludrocortisone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000173	0.0113	CcSEcCtD
Fludrocortisone—NR3C1—cardiac ventricle—dilated cardiomyopathy	0.000165	0.0746	CbGeAlD
Fludrocortisone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00016	0.0105	CcSEcCtD
Fludrocortisone—NR3C1—myocardium—dilated cardiomyopathy	0.000155	0.0702	CbGeAlD
Fludrocortisone—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000153	0.01	CcSEcCtD
Fludrocortisone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000152	0.00998	CcSEcCtD
Fludrocortisone—AR—heart—dilated cardiomyopathy	0.00015	0.0676	CbGeAlD
Fludrocortisone—AR—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.000147	0.0171	CbGpPWpGaD
Fludrocortisone—Erythema—Furosemide—dilated cardiomyopathy	0.000145	0.00951	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000145	0.0168	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000141	0.00924	CcSEcCtD
Fludrocortisone—Headache—Spironolactone—dilated cardiomyopathy	0.000136	0.00894	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000136	0.0158	CbGpPWpGaD
Fludrocortisone—Vertigo—Furosemide—dilated cardiomyopathy	0.00013	0.00855	CcSEcCtD
Fludrocortisone—AR—cardiac atrium—dilated cardiomyopathy	0.000128	0.0578	CbGeAlD
Fludrocortisone—Progesterone—NR3C2—dilated cardiomyopathy	0.00012	0.104	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.00012	0.0139	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000118	0.00776	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000114	0.0075	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000113	0.0131	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NR3C2—dilated cardiomyopathy	0.00011	0.0948	CrCbGaD
Fludrocortisone—Erythema—Lisinopril—dilated cardiomyopathy	0.000109	0.00714	CcSEcCtD
Fludrocortisone—NR3C1—heart—dilated cardiomyopathy	0.000108	0.049	CbGeAlD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000103	0.012	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	9.78e-05	0.0114	CbGpPWpGaD
Fludrocortisone—Vertigo—Lisinopril—dilated cardiomyopathy	9.77e-05	0.00641	CcSEcCtD
Fludrocortisone—Urticaria—Furosemide—dilated cardiomyopathy	9.4e-05	0.00617	CcSEcCtD
Fludrocortisone—NR3C1—cardiac atrium—dilated cardiomyopathy	9.27e-05	0.0419	CbGeAlD
Fludrocortisone—Myalgia—Lisinopril—dilated cardiomyopathy	9.26e-05	0.00608	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	8.87e-05	0.00582	CcSEcCtD
Fludrocortisone—Oedema—Lisinopril—dilated cardiomyopathy	8.87e-05	0.00582	CcSEcCtD
Fludrocortisone—Infection—Lisinopril—dilated cardiomyopathy	8.82e-05	0.00579	CcSEcCtD
Fludrocortisone—Hypersensitivity—Furosemide—dilated cardiomyopathy	8.71e-05	0.00572	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	8.58e-05	0.00563	CcSEcCtD
Fludrocortisone—Asthenia—Furosemide—dilated cardiomyopathy	8.49e-05	0.00557	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	8.08e-05	0.00531	CcSEcCtD
Fludrocortisone—Insomnia—Lisinopril—dilated cardiomyopathy	8.03e-05	0.00527	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	7.78e-05	0.00905	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	7.65e-05	0.0089	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	7.57e-05	0.0088	CbGpPWpGaD
Fludrocortisone—Headache—Furosemide—dilated cardiomyopathy	7.41e-05	0.00486	CcSEcCtD
Fludrocortisone—Urticaria—Lisinopril—dilated cardiomyopathy	7.05e-05	0.00463	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	6.63e-05	0.00771	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	6.54e-05	0.00429	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	6.37e-05	0.00741	CbGpPWpGaD
Fludrocortisone—Asthenia—Lisinopril—dilated cardiomyopathy	6.37e-05	0.00418	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	6.34e-05	0.00737	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LMNA—dilated cardiomyopathy	6.2e-05	0.00721	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	5.9e-05	0.00686	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	5.59e-05	0.0065	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	5.57e-05	0.00648	CbGpPWpGaD
Fludrocortisone—Headache—Lisinopril—dilated cardiomyopathy	5.56e-05	0.00365	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	5.31e-05	0.00618	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	4.6e-05	0.00536	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	4.24e-05	0.00493	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	4.15e-05	0.00483	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	4.03e-05	0.00469	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NPPA—dilated cardiomyopathy	3.64e-05	0.00424	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.64e-05	0.00423	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—FAS—dilated cardiomyopathy	3.62e-05	0.00421	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	3.51e-05	0.00408	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.51e-05	0.00408	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	3.49e-05	0.00406	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.44e-05	0.004	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—AGT—dilated cardiomyopathy	3.39e-05	0.00395	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	2.88e-05	0.00335	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR3C2—dilated cardiomyopathy	2.69e-05	0.00313	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	2.66e-05	0.0031	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.28e-05	0.00265	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	2.04e-05	0.00238	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	1.89e-05	0.0022	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.75e-05	0.00204	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NPPA—dilated cardiomyopathy	1.69e-05	0.00197	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.57e-05	0.00182	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	1.54e-05	0.00179	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.49e-05	0.00173	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.33e-05	0.00155	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	1.28e-05	0.00149	CbGpPWpGaD
